Clinical significance of hemophagocytosis in BM clot sections during the peri-engraftment period following allogeneic hematopoietic SCT.

scientific article published on 18 April 2011

Clinical significance of hemophagocytosis in BM clot sections during the peri-engraftment period following allogeneic hematopoietic SCT. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/BMT.2011.95
P698PubMed publication ID21499316
P5875ResearchGate publication ID51057160

P2093author name stringM Ito
K Watanabe
K Onodera
T Yasuda
T Goto
Y Inamoto
K Miyamura
S Tsukamoto
Y Ozawa
S Nishiwaki
D Koyama
A Seto
N Imahashi
M Imahashi
P2860cites workHematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCTQ24685958
Macrophage inflammatory protein-1Q28211059
A reversible posterior leukoencephalopathy syndromeQ28273132
Macrophage activation syndrome: advances towards understanding pathogenesisQ28284000
2. Cytokines and chemokinesQ30310536
Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease.Q33360369
Estimation of failure probabilities in the presence of competing risks: new representations of old estimatorsQ33594562
Pathophysiologic mechanisms of acute graft-vs.-host diseaseQ33793177
The phagocytes: neutrophils and monocytesQ34013216
The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donorsQ34128401
An overview of the immune systemQ34280088
Engraftment syndrome following hematopoietic stem cell transplantationQ34298239
Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.Q34537587
Hemophagocytic syndromesQ34641523
Hepatic Veno-occlusive Disease (Sinusoidal Obstruction Syndrome) After Hematopoietic Stem Cell TransplantationQ35126479
Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantationQ35934133
Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysisQ35994849
Human natural killer cellsQ36787596
Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapyQ37714121
Incidence, predisposing factors, and outcome of engraftment syndrome in pediatric allogeneic stem cell transplant recipientsQ40424504
Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: incidence and effects on survivalQ40505136
Hemophagocytic syndrome: a rare complication of allogeneic nonmyeloablative hematopoietic stem cell transplantationQ40581425
Inhibitors of haemopoiesis and their potential clinical relevance.Q41137657
Liposomal methylprednisolone differentially regulates the expression of TNF and IL-10 in human alveolar macrophagesQ45225864
Encouraging results of low-dose etoposide in the treatment of early-onset hemophagocytic syndrome following allogeneic hematopoietic stem cell transplantationQ46810363
Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.Q47804385
Impact of macrophage infiltration of skin lesions on survival after allogeneic stem cell transplantation: a clue to refractory graft-versus-host disease.Q50601549
Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathy.Q50622232
Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood.Q53620332
CD163Q56593680
Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantationQ73432062
Macrophages and their subpopulations following allogenic bone marrow transplantation for chronic myeloid leukaemiaQ74330699
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)387-394
P577publication date2011-04-18
P1433published inBone Marrow TransplantationQ4941523
P1476titleClinical significance of hemophagocytosis in BM clot sections during the peri-engraftment period following allogeneic hematopoietic SCT.
P478volume47

Reverse relations

cites work (P2860)
Q51028682Association of Plasma CD163 Concentration with De Novo-Onset Chronic Graft-versus-Host Disease.
Q50225125Dexamethasone palmitate for patients with engraftment syndrome is associated with favorable outcome for children with hematological malignancy
Q44295675Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation: macrophage-targeted steroid therapy
Q40889851Hemophagocytic syndrome following haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide.
Q48337197Increase of bone marrow macrophages and CD8+ T lymphocytes predict graft failure after allogeneic bone marrow or cord blood transplantation
Q27011625Making sense of the cytokine storm: a conceptual framework for understanding, diagnosing, and treating hemophagocytic syndromes
Q90703653My jamais vu in post allogeneic hematopoietic cell transplant: a review on secondary hemophagocytosis in adults
Q91813399Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation

Search more.